Cephalosporins are a class of β-lactam antibiotics similar to penicillin. They were first isolated from fungus in 1945 and work by inhibiting bacterial cell wall synthesis. There are several generations that have increased gram-negative spectrum. Common uses include skin/respiratory infections, sepsis, UTIs, and surgical prophylaxis. Adverse effects include hypersensitivity reactions, nephrotoxicity, and diarrhea. Resistance can develop through bacterial production of β-lactamases or changes to penicillin-binding proteins.
The current slide include the pharmacology og cephalosporins.
Contents
Introduction to Cephalosporins
Classification of Cephalosporins
Cefazolin
Cephalexin
Cefuroxime
Cefuroxime axetil
Cefotaxime
Cefixime
Cefpodoxime proxetil
Cefepime
Adverse effects of Cephalosporins
Uses of Cephalosporins
The current slide include the pharmacology og cephalosporins.
Contents
Introduction to Cephalosporins
Classification of Cephalosporins
Cefazolin
Cephalexin
Cefuroxime
Cefuroxime axetil
Cefotaxime
Cefixime
Cefpodoxime proxetil
Cefepime
Adverse effects of Cephalosporins
Uses of Cephalosporins
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
A nice introduction to Cephalosporins, how they work, the different generations, spectrum, uses, side effects, pharmacokinetics and common trade names in Egyptian market.
penicillins - power point - History,mechanism of action,classification,chemis...Dr. Ravi Sankar
Antibiotics - Penicillin's - power point - History, mechanism of action, classification, chemistry, SAR, Nomenclature, uses, side effects- Medicinal chemistry.
Prof. P. Ravisankar M. Pharm., Ph.D.
HOD .,
Vignan Pharmacy college
vadlamudi- Guntur-A.P, India.
banuman35@gmail.com
Phone: 0 9059994000
0 9000199106
This presentation gives a little details about 5th generation of cephalosporins and their usage.
it was done as a university presentation for Microbiology class.
Pharmacology of cephalosporins, monobactums and carbapenums including their mechanism of action, indications, adverse effects.
The various generations of cephalosporins and their spectrum of action
Cephalosporins & other β lactam antibiotics & cell wall destructorsFarazaJaved
this ppt cover all 5 generations of cephalosporins and about beta lactam atibiotics and cell wall destructors data available till now. hope u ll find it useful.
To enjoy the presentation kindly download it.
For Original view, download "Poetsen One" font style from dafont website.
Here I have discussed all the first to fifth generation cephalosporins.
2. β-Lactam antibiotics (beta-lactam
antibiotics)
• β-Lactam antibiotics (beta-lactam antibiotics)
are a broad class of antibiotics, consisting of
all antibiotic agents that contains a β-lactam
ring in their molecular structures. This
includes penicillin derivatives (penams),
cephalosporins (cephems), monobactams, and
carbapenems.
4. HISTORY OF CEPHALOSPORINS
• ISOLATED FROM CULTURES OF
CEPHALOSPORIUM ACREMONIUM
• IN 1945 –Italian scientist Brotzu
• Later cephalosporin-c is isolated in
University of Oxford
• 7amino cephalosporinic acid(7ACA)which
was derived from cephalosporin-c is
analogous to penicillin nucleus(6APA)
5. Cephalosporins
B-Lactam antibiotics ( similar to penicillins)
Broad spectrum
Act by inhibition of cell wall synthesis
Bactericidal
Inactive against : enterococci, MRSA, legionella ,
mycoplasma, chlamydia spp.
Widely used in surgical procedures to reduce the risk of
post operative infections
Cephalosporins are less succeptable to penicillinases
Disrupt synthesis of peptidoglycon layer
Final step of synthesis of peptidoglycon layer is inhibited
6. Pharmacological actions
• Earlier generation cephalosporins are G-positive
Successive generations have increased G-negativity
activity
• Cephalosporins reach poor conc. In c.s.f
7. Classification
• First generation (Moderate spectrum)
• Cefazolin · Cephalexin · Cephalosporin C ·
Cephalothin
• Second generation (Moderate spectrum)
• With anti-Haemophilus activity
• Cefaclor · Cefamandole · Cefuroxime
• With anti-anaerobic activity
• Cefotetan · Cefoxitin
• Third generation (Broad spectrum)
• Cefixime · Cefotaxime · Cefpodoxime ·
Ceftazidime · Ceftriaxone
• Fourth generation (Broad spectrum)
8. • (With β-lactamase stability and enhanced
activity against Gram-positive bacteria and
Pseudomonas aeruginosa)
• Cefepime · Cefpirome
• Fifth generation* (Broad spectrum)
• (Antipseudomonal in addition to activity
against MRSA and VRE. *Not universally
accepted nomenclature. )
• Ceftobiprol & Ceftaroline
9. FIRST GENERATION
Active against G+ cocci ( except.enterococci &
MRSA ):
S.pneumoniae, S.pyogenes,S. aureus,
S.epidermidis
Indicated for streptococcal pharyngitis ( e.g.
cephalexin)
Commonly used ( eg. Cefazolin) as prophylacic for
surgical procedures.
Modest activity against G- bacteria
10. SECOND GENERATION
Mainly effective against G- bacteria
Modest activity against G+ bacteria
Cefoxitin active against bowel anaerobes (B.
fragilis )
Cefuroxim active against H. influenzae, M.
catarrhalis, S. pneumoniae
Cef. Axetil- oral form of cefuroxim
11. Cefaclor active against H. influenzae, M.
catarrhalis &E.coli
Cefprozil- similar to cefaclor, c. axetil and
augmentin- Liked by children
Second Generations are used primarily for URTIs (
acute otitis media, sinusitis ) and Lower RTIs (
acute exacerbation of chronic bronchitis)
12. THIRD GENERATION
Ceftriaxone ( rocephin )
Cefotaxime ( claforan )
Cetazidime ( fortum )
Cefoperazone ( cefobid )
Cefixime ( suprax )
Cefpodoxime(Mahacef-O)
They have enhanced G- activity, H. influenzae, N.
meningitidis, N.gonorrhea, P. aeruginosae,
M. catarrhalis, E.coli, most Klebsiella
13. Ceftriaxone has long half-life . Not advised in
neonates (interferes with bilirubin
metabolism)
Cefotaxime preferred in neonate ( does not
interfere with bilirubin metabolism ), as may
ceftriaxone.
Ceftazidime & cefoperazone have excellent
activity against p. aeruginosae.
Cefixime has similar activity to amoxicillin &
cefaclor for actute otitis media
14. Fourth Generation
Cefipime
Active against G+ bacteria than cefazolin
against S. pyogenes, S.pneumoniae but lower
against S. aureus Similar to cefotaxime against
E.coli & K. pneumoniae but forp.aeruginosa.
15. Fifth generation
• Ceftaroline & ceftobiprole
• Fifth-generation cephalosporins are effective
against MRSA
• Ceftobiprole has powerful antipseudomonal
characteristics and appears to be less
susceptible to development of resistance.
Ceftaroline has also been described as "fifth-generation"
cephalosporin, but does not have
the anti-pseudomonal effect.
16. Pharmacokinetics
Cephalosporins are given parenterally and orally.
Extent of binding to plasma protein vary from one
to another.
e.g. Cefazolin is 80% protein bound ( hence, long
t1/2 )
Cephalexin is 10-15% protein bound
Relatively lipid insoluble ( like penicillins )
Hence,do not penetrate cells or the CNS, except for
third generations
17. Mostly excreted unchanged by the kidney
(glomerular & tubular secretion ), except,
ceftazidime & cefoperazone( glomerular)
Probenecid slows their elimination and prolong
their half-live ( except Ceftazidime &
cefoperazone)
Half-life 30-90 min; ceftriaxone 4-7 hr
18. Mechanism of action
• Cephalosporins are bactericidal and have the
same mode of action as other beta-lactam
antibiotics (such as penicillins) but are less
susceptible to penicillinases. Cephalosporins
disrupt the synthesis of the peptidoglycan layer
of bacterial cell walls. The peptidoglycan layer is
important for cell wall structural integrity. The
final transpeptidation step in the synthesis of the
peptidoglycan is facilitated by transpeptidases
known as penicillin-binding proteins (PBPs)
23. Adverse effects
1. Hypersensitivity reactions- most common
Anaphylaxis, bronchspasm, urticaria
Maculopapular rash- more common
10% of people who are sensitive to penicillins
sensitive to cephalosporins also.
2. Nephrotoxicity ; esp. cephradine
3. Thrombophlebitis ( i.v admin. )
4. Superinfections
5. Diarrhea-oral cephalosporins, cefoperazone,
ceftriaxone & moxalactam.
24. Adverse effects contd---
6. cefamandole, moxalactam & cefoperazone may cause:
a) bleeding disorders
b) Flushing, tachycardia, vomiting with alcohol
intake
7) Disulfiram like reactions when combined with
alcohol(newer)
8) Drug fever.
9)Blood Toxicity
includesHypoprothobenemia,abnormalities in
platelet aggregation,false positive coomb’s test with
certain cephalosporins likeCephalothin.
10) CNS irritation following intra thecal administration.
25. Bacterial Resistance
• Destruction of B-lactum ring by B-lactamases
• Altered affinity of cephalosporins
• Decreased penetration of antibiotic to
penicillin binding protein
• (Applicable to G-negative bacteria)
26.
27. Clinical applications
• Cephalosporins are used in the treatment of
infections caused by bacteria
• Cephalosporins are used to treat infections in
many different parts of the body. They are
sometimes given with other
antibiotics(Cefixime+Ofloxcillin )Some
cephalosporins given by injection are also used to
prevent infections before, during, and after
surgery. However, cephalosporins will not work
for colds, flu, or other virus infections
28. • cephalosporins are used in certain patients
with the following medical conditions
• Amoxicillin-resistant sinusitis (treatment)—
Cefaclor
• Bacterial endocarditis (prophylaxis)—
Cefadroxil, cefazolin, and cephalexin
• Melioidosis (treatment)—Ceftazidime
• Melioidosis is an infectious disease caused by
a Gram-negative bacterium, Burkholderia
pseudomalle.